CVE-2026-9128Studio 5000 Logix Designer® – Multiple Vulnerabilities
Updated under an hour ago ()
Does this affect you?
It affects Rockwell Automation Studio 5000 Logix Designer and 1 other product. Add what you run to find out whether that includes you.
No exploitation reported and no EPSS estimate yet.
Do this next
Free account, 1 product
A code execution security issue exists within Studio 5000 Logix Designer® due to an unquoted search path in the External Tools configuration. The executable paths specified in the external tools configuration file are not properly quoted, and because these paths contain spaces, the operating system may resolve them to unintended executables placed earlier in the search order. If exploited, an attacker could plant a malicious executable in a location within the search path, resulting in arbitrary code execution with the same permissions of the user running the application.
- CVSS
- 7.3 HIGH (v4.0, CNA)CVSS:4.0/AV:L/AC:H/AT:P/PR:L/UI:A/VC:H/VI:H/VA:H/SC:H/SI:H/SA:H
- Weakness (CWE)
- CWE-428
- Known exploited
- Not in CISA's KEV catalog
- EPSS (exploitation in the next 30 days)
- Not loaded for this CVE
- Assigned by
- Rockwell
- NVD analysis
- Analyzed
- Record last updated
- Jul 14, 2026
- First seen by InfoSec Signals
- Oct 9, 2026
Affected products
Rockwell Automation Studio 5000 Logix Designer rockwell_automation:studio_5000_logix_designer (from the name) | V35.00, 34.00-34.02, 33.00-33.02, 32.00-32.04 and older | CNA record |
rockwellautomation studio_5000_logix_designer rockwellautomation:studio_5000_logix_designer | before 32.05; from 33.00 before 33.03; from 34.00 before 34.03; 35.00 | NVD |
References
- https://www.rockwellautomation.com/en-us/trust-center/security-advisories/advisory.SD1783.htmlvendor-advisory
The CVE record on cve.org NVD's entry
The CVE record is authoritative. Products marked “from the name” were identified from the CNA's free-text names, not a CPE, and are matched less certainly. This product uses the NVD API but is not endorsed or certified by the NVD.